<DOC>
	<DOC>NCT00778700</DOC>
	<brief_summary>The study will be a double-blind, randomized, vehicle-controlled study with application of INCB018424 phosphate cream or vehicle in patients with stable plaque psoriasis. Application will be QD for 12 weeks without occlusive dressings. There will be 4 treatments of 50 subjects each.</brief_summary>
	<brief_title>A Dose Ranging Study of the Effect of INCB018424 Phosphate Cream When Applied to Patients With Plaque Psoriasis</brief_title>
	<detailed_description />
	<mesh_term>Psoriasis</mesh_term>
	<criteria>Plaque psoriasis involving up to 2 to 20% Body Surface Area Lesions solely involving intertriginious areas, the scalp or the face Systemic therapy for their psoriasis Pustular psoriasis or erythroderma Currently on other topical agents or UVB therapy within 2 weeks of the first dose of study medication Started or discontinued therapy within 2 months of Screening with agents that can exacerbate psoriasis Receiving systemic triazole antifungals except fluconazole</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>March 2012</verification_date>
</DOC>